We are analyzing https://link.springer.com/article/10.1007/s40744-022-00424-1.

Title:
Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort | Rheumatology and Therapy
Description:
Introduction Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA) patients. The most commonly involved organs in such condition are the lungs, skin, and lymph nodes. The aim of this study is to report the number of cases and the clinical manifestations of sarcoidosis induced by anti-TNF in our RA UCLouvain Brussels cohort. Methods All case records of RA patients ever treated with a TNF inhibitor and presenting anti-TNF induced sarcoidosis in our rheumatology centers from 2000 to 2021 were retrospectively reviewed. Results Our RA UCLouvain Brussels cohort includes 2492 patients. Among them, 697 patients have been or are exposed to a TNF inhibitor. Only four patients with sarcoidosis induced by anti-TNF were identified and reviewed. Patient 1 was classified as incomplete Heerfordt syndrome. Patient 2 was a case of sarcoid-like granulomatosis manifesting as life-threatening hypercalcemia, acute kidney injury and atypical parenchymal pneumopathy. Patients 3 and 4 developed pulmonary sarcoidosis with hilar adenopathies. The TNF inhibitor was etanercept for the first three patients and infliximab for the last one. The time occurrence of sarcoidosis was highly variable after anti-TNF exposure. All patients recovered after glucocorticoid treatment and the discontinuation of the anti-TNF agent. Conclusions This case highlights this rare paradoxical side effect and the variability of the clinical presentation. Further studies should analyze the immunopathology of such conditions.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

sarcoidosis, article, patients, google, scholar, antitnf, arthritis, therapy, etanercept, treatment, disease, rheumatoid, patient, cas, cases, treated, clinical, induced, cohort, tnf, pulmonary, agent, methotrexate, review, brussels, necrosis, agents, granulomatosis, rheumatol, uclouvain, case, factor, paradoxical, years, med, data, rheumatology, effect, report, authors, rare, side, study, sarcoidlike, infliximab, observed, granulomas, privacy, cookies, analysis,

Topics {✒️}

anti-tumor necrosis factor anti-tnf-induced sarcoidosis highlight elevated c-reactive protein high angiotensin-converting enzyme cliniques universitaires saint-luc underwent chest x-ray anti-tnf-induced psoriasis [7] article download pdf anti-tnf induced sarcoidosis anti-tnf induced sarcoidosis anti-tnf agent developed full access anti-tnf agent exposure tnf agent-induced sarcoidosis drug-induced sarcoidosis drug-induced sarcoidosis sarcoid-related uveitis occurring rheumatoid arthritis patients privacy choices/manage cookies patients characteristics tnf-induced psoriasis adalimumab-induced sarcoidosis acute kidney injury anti-tnf exposure anti-tnf therapy high clinical suspicion anti-tnf agent semin arthritis rheum systemic sarcoidosis induced monoclonal anti-tnf pulmonary rheumatoid nodules aleksandra avramovska laboratory findings showed life-threatening hypercalcemia paradoxical side effect anti-tnf agents laboratory test showed tnf blood level fdg-pet ct medical record files lung injury linked rare side effect immune checkpoint inhibitors slightly elevated crp anti-tnfα factors anti-tnf treatment lymph node biopsy european economic area main content log rheumatoid arthritis

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort
         description:Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA) patients. The most commonly involved organs in such condition are the lungs, skin, and lymph nodes. The aim of this study is to report the number of cases and the clinical manifestations of sarcoidosis induced by anti-TNF in our RA UCLouvain Brussels cohort. All case records of RA patients ever treated with a TNF inhibitor and presenting anti-TNF induced sarcoidosis in our rheumatology centers from 2000 to 2021 were retrospectively reviewed. Our RA UCLouvain Brussels cohort includes 2492 patients. Among them, 697 patients have been or are exposed to a TNF inhibitor. Only four patients with sarcoidosis induced by anti-TNF were identified and reviewed. Patient 1 was classified as incomplete Heerfordt syndrome. Patient 2 was a case of sarcoid-like granulomatosis manifesting as life-threatening hypercalcemia, acute kidney injury and atypical parenchymal pneumopathy. Patients 3 and 4 developed pulmonary sarcoidosis with hilar adenopathies. The TNF inhibitor was etanercept for the first three patients and infliximab for the last one. The time occurrence of sarcoidosis was highly variable after anti-TNF exposure. All patients recovered after glucocorticoid treatment and the discontinuation of the anti-TNF agent. This case highlights this rare paradoxical side effect and the variability of the clinical presentation. Further studies should analyze the immunopathology of such conditions.
         datePublished:2022-02-08T00:00:00Z
         dateModified:2022-02-08T00:00:00Z
         pageStart:763
         pageEnd:770
         license:http://creativecommons.org/licenses/by-nc/4.0/
         sameAs:https://doi.org/10.1007/s40744-022-00424-1
         keywords:
            Rheumatoid arthritis
            Anti-TNF
            Tumor necrosis factor inhibitor
            Sarcoidosis
            Drug-induced sarcoidosis
            Rheumatology
            Orthopedics
            General Practice / Family Medicine
            Internal Medicine
            Quality of Life Research
         image:
         isPartOf:
            name:Rheumatology and Therapy
            issn:
               2198-6584
               2198-6576
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Healthcare
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xavier Theunssens
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura Bricman
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stéphanie Dierckx
               affiliation:
                     name:CHU Mont Godinne
                     address:
                        name:Rheumatology, CHU Mont Godinne, Yvoir, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emilie Sapart
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tatiana Sokolova
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aleksandra Avramovska
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrick Durez
               url:http://orcid.org/0000-0002-7156-2356
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort
      description:Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA) patients. The most commonly involved organs in such condition are the lungs, skin, and lymph nodes. The aim of this study is to report the number of cases and the clinical manifestations of sarcoidosis induced by anti-TNF in our RA UCLouvain Brussels cohort. All case records of RA patients ever treated with a TNF inhibitor and presenting anti-TNF induced sarcoidosis in our rheumatology centers from 2000 to 2021 were retrospectively reviewed. Our RA UCLouvain Brussels cohort includes 2492 patients. Among them, 697 patients have been or are exposed to a TNF inhibitor. Only four patients with sarcoidosis induced by anti-TNF were identified and reviewed. Patient 1 was classified as incomplete Heerfordt syndrome. Patient 2 was a case of sarcoid-like granulomatosis manifesting as life-threatening hypercalcemia, acute kidney injury and atypical parenchymal pneumopathy. Patients 3 and 4 developed pulmonary sarcoidosis with hilar adenopathies. The TNF inhibitor was etanercept for the first three patients and infliximab for the last one. The time occurrence of sarcoidosis was highly variable after anti-TNF exposure. All patients recovered after glucocorticoid treatment and the discontinuation of the anti-TNF agent. This case highlights this rare paradoxical side effect and the variability of the clinical presentation. Further studies should analyze the immunopathology of such conditions.
      datePublished:2022-02-08T00:00:00Z
      dateModified:2022-02-08T00:00:00Z
      pageStart:763
      pageEnd:770
      license:http://creativecommons.org/licenses/by-nc/4.0/
      sameAs:https://doi.org/10.1007/s40744-022-00424-1
      keywords:
         Rheumatoid arthritis
         Anti-TNF
         Tumor necrosis factor inhibitor
         Sarcoidosis
         Drug-induced sarcoidosis
         Rheumatology
         Orthopedics
         General Practice / Family Medicine
         Internal Medicine
         Quality of Life Research
      image:
      isPartOf:
         name:Rheumatology and Therapy
         issn:
            2198-6584
            2198-6576
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Healthcare
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xavier Theunssens
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura Bricman
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stéphanie Dierckx
            affiliation:
                  name:CHU Mont Godinne
                  address:
                     name:Rheumatology, CHU Mont Godinne, Yvoir, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emilie Sapart
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tatiana Sokolova
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aleksandra Avramovska
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrick Durez
            url:http://orcid.org/0000-0002-7156-2356
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Rheumatology and Therapy
      issn:
         2198-6584
         2198-6576
      volumeNumber:9
Organization:
      name:Springer Healthcare
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:CHU Mont Godinne
      address:
         name:Rheumatology, CHU Mont Godinne, Yvoir, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xavier Theunssens
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Laura Bricman
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Stéphanie Dierckx
      affiliation:
            name:CHU Mont Godinne
            address:
               name:Rheumatology, CHU Mont Godinne, Yvoir, Belgium
               type:PostalAddress
            type:Organization
      name:Emilie Sapart
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Tatiana Sokolova
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Aleksandra Avramovska
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Patrick Durez
      url:http://orcid.org/0000-0002-7156-2356
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
      name:Rheumatology, CHU Mont Godinne, Yvoir, Belgium
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium
      name:Rheumatology, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium

External Links {🔗}(106)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.86s.

LINK . SPRINGER . COM {}